EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Libocedroquinone: A Promising Anticancer Lead against Lung Cancer from Calocedrus Decurrens

Santhi Subramanyan, Varsha Karunakaran, Selvakumar Deepika, Anuja Joseph Gracy, Veluthoor Sheeba, Karchesy Joseph, Kaustabh Kumar Maiti, Ramavarma Luxmi Varma, Kokkuvayil Vasu Radhakrishnan

Planta Medica International Open · 2022-06-01 · 9 (01) · e54-e59

DOI: 10.1055/a-1699-8748 ↗
AbstractBibliografische Angaben

Abstract

Abstract A focus on evaluating anticancer potency of various extracts of the heartwood of Calocedrus decurrens against human lung adenocarcinoma (A549) cell line was performed using in vitro MTT assay. The hexane extract displayed excellent cytotoxic effect, and the phytochemical investigation of the hexane and acetone extracts resulted in the isolation of five major compounds. The structure of the compounds was established as libocedrol (1), thymoquinone (2), libocedroquinone (3), diethylphthalate (4), and (1 R, 2 R, 4 R)-p-menthane-1,2,4-triol (5). Compounds 4 and 5 are reported for the first time from the Calocedrus genus. Compounds 1–3 were evaluated for their cytotoxicity against the lung cancer cell line along with a healthy control. Compound 3 was more potent than other compounds against the A549 cell line with an IC50 of 4.8 µM at 24 h. Moreover, compound 3 exhibited less toxicity with the normal lung fibroblast cell line WI-38. This is the first anticancer study of the species Calocedrus decurrens.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →